Safer personalized cancer follow-up with digital tools
Part of Cancer clinical trials.
This study tests a personalized digital follow-up system for cancer patients receiving immunotherapy. It aims to make your care safer and more tailored to you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a cancer diagnosis (but not blood cancer or gynecological cancer)
- You are receiving immunotherapy (a treatment that boosts your immune system to fight cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores how digital tools (apps or websites) can help people affected by cancer, including patients, caregivers, and healthcare workers. If you are a current or past cancer patient, a caregiver, or an oncology professional, you may be able to join.
This trial tests a smartphone-based follow-up program for people who have been treated for early-stage colorectal cancer. The goal is to see if a digital, need-based care guide can replace standard follow-up visits.
This study collects health data from digital devices (like Apple iPhone or Android) to help researchers understand how physical activity and other measures change during cancer treatment. It may be a way for you to contribute to research from home.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
This trial tests a platform where you can track your experiences and concerns about cancer medications. It aims to help you and your care team manage medication safety.
This trial tests whether combining regular medication safety checks with electronic tracking of side effects can improve quality of life and help reduce economic burden for people taking cancer pills. It’s for people starting oral cancer therapy and using connected technology to report symptoms.
Hear when a new Patient Reported Outcome Measure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.